# Ropivacaine Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 49 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Caplin Steriles, Ltd. — Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) — FDA availability: Available — updated: 06/10/2026 - Caplin Steriles, Ltd. — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) — FDA availability: Limited Availability — updated: 06/10/2026 - Caplin Steriles, Ltd. — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) — FDA availability: Available — updated: 06/10/2026 - Caplin Steriles, Ltd. — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) — FDA availability: Limited Availability — updated: 06/10/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) — FDA availability: Unavailable — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) — FDA availability: Available — updated: 08/04/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) — FDA availability: Limited Availability — updated: 08/18/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) — FDA availability: Unavailable — updated: 08/18/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) — FDA availability: Available — updated: 08/18/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) — FDA availability: Available — updated: 08/18/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) — FDA availability: Available — updated: 08/18/2026 - InfoRLife SA — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) — FDA availability: Available — updated: 08/18/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) — FDA availability: Available — updated: 07/20/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/ropivacaine-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/ropivacaine-hydrochloride-injection.json)